The 20 Best Diabetic Nephropathy Doctors Near Me in Nottingham, MD

Adline Ghazi is an Endocrinologist in Baltimore, Maryland. Dr. Ghazi is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Thyroid Hormone Plasma Membrane Transport Defect, and Generalized Resistance to Thyroid Hormone.

Errol Rushovich is an Endocrinologist in Nottingham, Maryland. Dr. Rushovich has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Hypothyroidism, Obesity in Children, Type 2 Diabetes (T2D), and Osteoporosis.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.

Rochelle Cunningham is a Nephrologist in Baltimore, Maryland. Dr. Cunningham is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Glomerulonephritis, and Diabetic Nephropathy.

Kenneth Yim is a Nephrologist in Baltimore, Maryland. Dr. Yim is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Acute Kidney Failure, Nephrosclerosis, End-Stage Renal Disease (ESRD), and High Potassium Level.

Shari Lewis is a Nephrologist in Baltimore, Maryland. Dr. Lewis is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, End-Stage Renal Disease (ESRD), Renovascular Hypertension, and Chronic Kidney Disease.

Dipti Patel is a Nephrologist in Rosedale, Maryland. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Necrosis.

Akshay Amin is a Nephrologist in Baltimore, Maryland. Dr. Amin is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Diabetic Nephropathy.

Mark Corriere is an Endocrinologist in Towson, Maryland. Dr. Corriere is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Nodule, and Hypothyroidism.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Hormone Replacement Therapy (HRT).

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Dr. Sumeska Thavarajah is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of expertise include nephrology. Dr. Thavarajah earned her M.D. at Wayne State University School of Medicine. She completed her residency at the University of Connecticut Health Center and performed nephrology fellowships at Johns Hopkins Bayview Medical Center and the University of Connecticut Health Center. She serves as chair of the National Kidney Foundation of Maryland’s Medical Advisory Board. She was recognized by the National Kidney Foundation of Maryland with a Linda Cameron Award for Patient Services in 2015. Courses & Syllabi Nephrology Elective (Consultation Service),, Bayview Medical Center, 1/1/15. Dr. Thavarajah is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Nephrosclerosis, and Renovascular Hypertension.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Gestational Diabetes, and Type 1 Diabetes (T1D).

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Nephrosclerosis, and Kidney Transplant.

Rexford Ahima is an Endocrinologist in Baltimore, Maryland. Dr. Ahima is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Obesity, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Sleeve Gastrectomy, and Gastric Bypass.

Dr. Mohamad Hanouneh is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Hanouneh grew up in Syria and completed his medical school in Tishreen University in Latakia, Syria. He completed Internal Medicine Residency training at Cleveland Clinic, and Nephrology Fellowship at Johns Hopkins. Dr. Hanouneh currently serves as a part-time faculty in the Division of Nephrology at Johns Hopkins. He also works in the Nephrology Center of Maryland covering Good Samaritan and Upper Chesapeake Hospitals. Dr. Hanouneh has a passion in medical education. He runs the nephrology board review course and participates in Genes to Society Course of Renal Physiology, which is given to the medical students at Johns Hopkins University School of Medicine. His area of interests are electrolytes disorders, diabetic kidney disease and nephrolithiasis. Dr. Hanouneh is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Low Potassium Level, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and High Potassium Level.

Dr. Crews is a Professor of Medicine in the Division of Nephrology at the Johns Hopkins University School of Medicine. She holds faculty appointments with the School of Nursing, the Welch Center for Prevention, Epidemiology and Clinical Research, the Center on Aging and Health, and the Center for Health Equity, where she is Deputy Director. Her research program aims to advance equity in kidney disease and hypertension outcomes by focusing on social drivers of health inequities. An elected member of the American Society for Clinical Investigation, Dr. Crews has received numerous awards for her research contributions, including the 2018 Johns Hopkins University President’s Frontier Award--a $250,000 award granted to a single faculty scholar on the cusp of transforming their field. She is a former National Academy of Medicine (NAM) Emerging Leader Scholar and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. In 2019, Dr. Crews received the W. Lester Henry Award for Diversity and Access to Care from the American College of Physicians and the Distinguished Leader Award from the American Society of Nephrology. Dr. Crews is the founding director of the Doctoral Diversity Program, a 2-year, research-intensive post-baccalaureate program of the Johns Hopkins Initiative for Careers in Science and Medicine. Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master’s in clinical epidemiology degree at Johns Hopkins. Dr. Crews is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Arteriovenous Malformation, Kidney Transplant, and Nephrectomy.

Dr. Nada Alachkar is an associate professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include incompatible kidney transplants, kidney transplants, nephrology and pancreas transplants. Dr. Alachkar earned her M.D. at Aleppo University Faculty of Medicine in Syria. She completed residencies at Aleppo University and Wright State University School of Medicine. She performed clinical fellowship in nephrology and transplant nephrology fellowship at Johns Hopkins University. Her research interests include recurrent glomerular diseases post kidney transplantation; in particular recurrent FSGS post transplant. Also, she is studying biomarkers in kidney transplants; outcome of living and deceased donor kidney transplant recipients with positive crossmatch; and responses to desensitization treatments and post-transplant outcome in highly sensitized patients. Dr. Alachkar is a member of the American Society of Nephrology and the American Society of Transplantation. Dr. Alachkar is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Focal Segmental Glomerulosclerosis, Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Kidney Transplant, and Splenectomy.